RRM2 overexpression, for example, promoted the gastric cancer invasion capacity, while its silencing inhibited the proliferation, invasion, and migration of lung cancer cells and other malignant phenotypes (Morikawa et al., 2010; Yang et al., 2019; Jiang et al., 2021). Here, RRM2 is linked to gastric cancer.